Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Latest Articles Spotlight Titles

Jan 1, 2016

Featured Articles

Parker Waichman LLP is here to help; it’s what we do, all day for thousands of individuals just like you throughout the country. Contact us today for a free case evaluation. YOURLAWYER.com has been designed with you in mind to be an information-rich legal resource for you, providing up-to-date legal information.

Topics Page

Articles in the News

Below are the most significant articles making the biggest headlines today.

Hot Articles

Talcum Powder Ovarian Cancer Trial Scheduled for Early February 2017


Talcum Powder

Hundreds of talcum powder ovarian cancer lawsuits continue to move toward trial in a consolidated litigation underway in federal court in Missouri. A pretrial order issued on June 20, 2016 changed a trial starting date of February 21, 2017 to February 6, 2017.

The cases to be tried involves six plaintiffs who claim that regular, repeated use of Johnson & Johnson's talc-based Baby Powder and Shower to Shower powder contributed to the development of ovarian cancer...

READ MORE

FDA Has Twice Ordered Black Box Warnings for Xarelto


FDA Has Twice Ordered Black Box Warnings for Xarelto

Since the Food and Drug Administration (FDA) approved the new-generation blood-thinning drug Xarelto in 2011, the agency has ordered two separate black box warnings for Xarelto.

Black box warnings-where the information is enclosed in a black box to draw attention -are the FDA's most serious label warnings. A black box warning is sometimes the precursor to a drug being removed from the market.

Xarelto (rivaroxaban) was approved to treat patients at risk for blood clots from medical conditions such as atrial fibrillation, pulmonary embolism, and deep vein thrombosis, and for people at risk for blood clots during recovery from knee and hip replacement surgeries...

READ MORE


Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo